Thijs J. Beldman - Concepedia

Author

Thijs J. Beldman

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Thijs Beldman, Thijs J. Beldman

Publications

851

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Eindhoven University of Technology Radboud University Nijmegen Radboud University Medical Center Amsterdam University Medical Centers

About

Thijs J. Beldman is an author at Icahn School of Medicine at Mount Sinai specializing in biomedical engineering, engineering, and nanoparticles.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	49
2	Biomedical Engineering	2	2	49
3	Medicine	1	1	16
4	Biomolecular Engineering	1	1	16
5	Immunology	1	1	16

Thijs J. Beldman

Publications

535

Citations

H-Index

Page 1

	Year	Citations
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis Thijs J. Beldman, Max L. Senders, Amr Alaarg, ACS Nano	2017	185
Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy Thijs J. Beldman, Tsveta S. Malinova, Emilie Desclos, ACS Nano	2019	104
Prosaposin mediates inflammation in atherosclerosis Mandy M. T. van Leent, Thijs J. Beldman, Yohana C. Toner, Science Translational Medicine	2021	92
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells David P. Schrijver, Rutger J. Röring, Jeroen Deckers, Nature Biomedical Engineering	2023	71
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors Stijn R. J. Hofstraat, Tom Anbergen, Robby Zwolsman, Nature Nanotechnology NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringNature-inspired Platform Nanotechnology	2025	33
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy Annelies C. Wauters, Jari F. Scheerstra, Mandy M. T. van Leent, Nature Nanotechnology	2024	22
Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics David P. Schrijver, Anne de Dreu, Stijn R. J. Hofstraat, Advanced Therapeutics NanoparticlesNanotherapeuticsEngineeringAdaptive Immune SystemInnate Immune System	2021	16
Diverse ultrastructural landscape of atherosclerotic endothelium Ewelina Kluza, Thijs J. Beldman, Annelie Shami, Atherosclerosis	2021	12

Page 1